back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2026-05-21 16:27 Tx date 2026-05-20 |
$ZOMDF
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Powers, Johnny
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,044
+97,515 vol $0.103 each |
4,425,000 | |
| Filed 2026-05-21 16:27 Tx date 2026-05-19 |
$ZOMDF
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Powers, Johnny
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$255.95
+2,485 vol $0.103 each |
4,327,485 | |
| Filed 2026-05-21 16:26 Tx date 2026-05-18 |
$ZOMDF
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Powers, Johnny
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,300
+100,000 vol $0.103 each |
4,325,000 | |
| Filed 2026-05-21 16:20 Tx date 2026-05-21 |
$ZOMDF
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Klass, Russell Kevin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$577.50
+5,500 vol $0.105 each |
6,001,000 | |
| Filed 2026-05-21 16:19 Tx date 2026-05-21 |
$ZOMDF
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Klass, Russell Kevin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,219
+11,399 vol $0.107 each |
5,995,500 | |
| Filed 2026-05-21 16:18 Tx date 2026-05-20 |
$ZOMDF
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Klass, Russell Kevin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$21,000
+200,000 vol $0.105 each |
5,984,101 | |
| Filed 2026-05-14 16:22 Tx date 2026-05-13 |
$ZOMDF
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Powers, Johnny
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$21,200
+200,000 vol $0.106 each |
4,225,000 | |
| Filed 2026-05-14 16:21 Tx date 2026-05-12 |
$ZOMDF
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Powers, Johnny
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,500
+100,000 vol $0.105 each |
4,025,000 | |
| Filed 2026-05-11 16:34 Tx date 2026-05-11 |
$ZOMDF
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Powers, Johnny
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$44,197
+391,129 vol $0.113 each |
3,925,000 | |
| Filed 2026-05-11 16:33 Tx date 2026-05-08 |
$ZOMDF
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Powers, Johnny
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$12,193
+108,871 vol $0.112 each |
3,533,871 | |
| Filed 2026-05-08 16:10 Tx date 2026-05-08 |
$ZOMDF
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Heaton, Larry C.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$27,500
+250,000 vol $0.11 each |
1,250,000 | |
| Filed 2025-11-18 17:46 Tx date 2025-11-17 |
$ZOMDF
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Williams, Rodney
4 - Director of Issuer
Direct Ownership
|
Rights (Stock Appreciation Rights)
56 - Grant of rights
|
$197,503
+1,975,033 vol $0.10 each |
3,950,066 | |
| Filed 2025-11-18 17:44 Tx date 2024-11-11 |
$ZOMDF
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Williams, Rodney
4 - Director of Issuer
Direct Ownership
|
Rights (Stock Appreciation Rights)
56 - Grant of rights
|
$256,754
+1,975,033 vol $0.13 each |
1,975,033 | |
| Filed 2025-11-18 17:42 Tx date 2016-04-21 |
$ZOMDF
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Williams, Rodney
4 - Director of Issuer
Direct Ownership
|
Rights (Stock Appreciation Rights)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-11-18 17:36 Tx date 2025-11-17 |
$ZOMDF
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Whelan, Sean
4 - Director of Issuer
Direct Ownership
|
Rights (Stock Appreciation Rights)
56 - Grant of rights
|
$197,503
+1,975,033 vol $0.10 each |
3,950,066 | |
| Filed 2025-11-18 17:34 Tx date 2024-11-11 |
$ZOMDF
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Whelan, Sean
4 - Director of Issuer
Direct Ownership
|
Rights (Stock Appreciation Rights)
56 - Grant of rights
|
$256,754
+1,975,033 vol $0.13 each |
1,975,033 | |
| Filed 2025-11-18 17:33 Tx date 2021-09-13 |
$ZOMDF
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Whelan, Sean
4 - Director of Issuer
Direct Ownership
|
Rights (Stock Appreciation Rights)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-11-18 17:29 Tx date 2025-11-17 |
$ZOMDF
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Rights (Stock Appreciation Rights)
56 - Grant of rights
|
$212,695
+2,126,959 vol $0.10 each |
4,253,918 | |
| Filed 2025-11-18 17:27 Tx date 2024-11-11 |
$ZOMDF
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Rights (Stock Appreciation Rights)
56 - Grant of rights
|
$276,504
+2,126,959 vol $0.13 each |
2,126,959 | |
| Filed 2025-11-18 17:26 Tx date 2016-04-21 |
$ZOMDF
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Rights (Stock Appreciation Rights)
00 - Opening Balance-Initial SEDI Report
|